156 related articles for article (PubMed ID: 3144615)
1. [A randomized controlled trial comparing short-term MF chemotherapy with MF plus long-term HCFU chemotherapy as an adjuvant to a curative resection of stomach cancer: Mifurol Study Group for Stomach Cancer].
Yamamura Y; Nakazato H; Koike A; Ichihashi H
Gan No Rinsho; 1988 Nov; 34(14):1936-42. PubMed ID: 3144615
[TBL] [Abstract][Full Text] [Related]
2. [A randomized controlled trial comparing short-term MF chemotherapy with MF and long-term carmofur chemotherapy as an adjuvant to curative resection of stomach cancer].
Nakazato H; Koike A; Ichihashi H
Gan No Rinsho; 1986 Feb; 32(2):159-64. PubMed ID: 3083146
[TBL] [Abstract][Full Text] [Related]
3. [Mitomycin C plus HCFU adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma. (Second report): 5-year survival rate. Cooperative Study Group of Kyushu and Chugoku for HCFU Adjuvant Chemotherapy].
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):333-9. PubMed ID: 2494948
[TBL] [Abstract][Full Text] [Related]
4. [Prospective adjuvant chemotherapy, with mitomycin C plus long-term carmofur in colorectal cancer].
Terabe K; Yamauchi M; Watanabe T; Ichihashi H; Takagi H; Imaizumi M; Kondo T
Gan No Rinsho; 1986 Mar; 32(3):261-7. PubMed ID: 3086597
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report).
Niimoto M; Hattori T; Tamada R; Sugimachi K; Inokuchi K; Ogawa N
Jpn J Surg; 1987 Sep; 17(5):354-61. PubMed ID: 3123756
[TBL] [Abstract][Full Text] [Related]
6. [A randomized controlled trial of immunochemotherapy using carmofur (HCFU), mitomycin C and immunopotentiators in advanced gastric cancer following noncurative resection and nonresection].
Nakanishi Y
Gan No Rinsho; 1986 May; 32(5):475-80. PubMed ID: 3088298
[TBL] [Abstract][Full Text] [Related]
7. [Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy].
Ichihashi H; Yamauchi M; Watanabe T; Takagi H; Kondo T
Gan No Rinsho; 1988 Apr; 34(4):451-6. PubMed ID: 3128670
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
[TBL] [Abstract][Full Text] [Related]
9. [Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer].
Osawa S; Shiroto H; Kondo Y; Nakanishi Y; Fujisawa J; Miyakawa K; Oku T; Nishimura A; Uchino J
Gan To Kagaku Ryoho; 1996 Feb; 23(3):327-31. PubMed ID: 8712826
[TBL] [Abstract][Full Text] [Related]
10. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
[TBL] [Abstract][Full Text] [Related]
11. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
[TBL] [Abstract][Full Text] [Related]
12. [Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Sadahiro S; Mitomi T; Noto T; Kumada K; Hiki Y; Yamakawa T; Amano T; Oki S; Otani Y; Oka H; Takahashi T; Takemiya S; Nishiyama K; Yamamura T; Tsuchiya S; Ogawa N;
Gan To Kagaku Ryoho; 2005 Jul; 32(7):997-1005. PubMed ID: 16044962
[TBL] [Abstract][Full Text] [Related]
13. Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer.
Ito K; Yamaguchi A; Miura K; Kato T; Koike A; Takagi H
J Surg Oncol; 1996 May; 62(1):4-9. PubMed ID: 8618399
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
Yokomori T; Taniguchi T; Iesato H; Sakata Y; Watanabe T; Kawabe K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3064-70. PubMed ID: 2960267
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.
Nakajima T; Nashimoto A; Kitamura M; Kito T; Iwanaga T; Okabayashi K; Goto M
Lancet; 1999 Jul; 354(9175):273-7. PubMed ID: 10440302
[TBL] [Abstract][Full Text] [Related]
17. [A randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for gastric cancer: the second study (III)].
Muto T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Nakajima T; Kikuchi K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1863-70. PubMed ID: 6433808
[TBL] [Abstract][Full Text] [Related]
18. [Conditions suitable for the adjuvant chemotherapy of gastric cancer].
Nakajima T; Takahashi T; Takagi K; Kuno K; Kajitani T
Gan No Rinsho; 1983 Aug; 29(10):1229-36. PubMed ID: 6415314
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
Tsavaris NB; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekois D; Tsetis A; Klonaris C
Am J Clin Oncol; 1996 Oct; 19(5):517-21. PubMed ID: 8823483
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant chemotherapy for gastric cancer--the third study. First report: central randomization by telephone method and analysis of patients' background factors].
Kunii Y; Kikuchi K; Tanabe T; Abe O; Kondo T; Taguchi T; Hattori T; Komi N; Nakazato H; Nakajima T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):349-55. PubMed ID: 2494949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
